Digoxin for the treatment of chronic and acute heart failure syndromes.
Digoxin for the treatment of chronic and acute heart failure syndromes.
复制标题
DOI：
10.1080/17482940902883246
复制
发表时间：
2009-01-01
期刊：
影响因子：
--
通讯作者：
Filippatos, Gerasimos S
中科院分区：
文献类型：
--
作者：
Gheorghiade, Mihai;Harinstein, Matthew E;Filippatos, Gerasimos S
洋地黄制剂已经使用了几个世纪。地高辛是一种易于获得的药物，可以急性和长期静脉或口服给药，是安全的，对急性和慢性心力衰竭(HF)都有好处。它可能是治疗急性心力衰竭综合征的理想药物，值得在大型临床试验中进行进一步研究。2008年10月25日至28日在法国凡尔赛举行的2008年欧洲心脏病学会急性心脏护理工作组会议上讨论了地高辛在急性和慢性心力衰竭中的作用。本报告是本次会议发言的摘要。
Digitalis preparations have been used for centuries. Digoxin is an agent that is readily available, can be administered acutely and long-term, intravenously or orally, is safe and may be beneficial in both acute and chronic heart failure (HF). It may be an ideal drug for the treatment of acute heart failure syndromes and warrants further investigation in large clinical trials. The role of digoxin in acute and chronic HF was discussed at the 2008 European Society of Cardiology Working Group on Acute Cardiac Care Meeting held in Versailles, France from 25-28 October 2008. This report represents a summary of the presentation at this meeting.